Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Sell
5,176
-576
-10% -$197K 1.15% 22
2026
Q1
$2.02M Buy
5,752
+1,078
+23% +$384K 1.44% 16
2025
Q4
$1.53M Buy
4,674
+1,302
+39% +$413K 1.02% 25
2025
Q3
$952K Buy
3,372
+96
+3% +$27.8K 0.8% 35
2025
Q2
$915K Sell
3,276
-26
-0.8% -$7.37K 0.84% 32
2025
Q1
$1.03M Buy
3,302
+26
+0.8% +$7.68K 1.14% 22
2024
Q4
$854K Buy
+3,276
New +$972K 0.92% 26

Other funds holding AMGN

Petros Family Wealth's AMGN Position: Q2 2026 in Review

Petros Family Wealth reduced its Amgen (AMGN) stake by 10% in Q2 2026, selling an estimated $197K and leaving 5,176 shares worth $1.87M. The position accounts for 1.15% of the portfolio, ranked #22.

Petros Family Wealth first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.02M in Q1 2026. 1,152 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Petros Family Wealth held 5,176 shares of Amgen worth $1.87M as of Q2 2026.
  • Petros Family Wealth sold 576 Amgen shares in Q2 2026, an estimated $197K.
  • Amgen made up 1.15% of Petros Family Wealth's portfolio in Q2 2026, its #22 holding.
  • Petros Family Wealth first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Petros Family Wealth's Amgen position peaked at $2.02M in Q1 2026.
  • 1,152 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Petros Family Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.